CIK 0001735438 · Non-accelerated filer<br>Smaller reporting company
MeiraGTx Holdings plc
Sign in to watch- Ticker
- MGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981448305
- Phone
- 646-860-7985
- Business address
- 655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,710,812
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,710,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Harris Keith R. Director | Grant or award · Restricted Share Units | +75,000 | 75,000 | ||
| 2024-06-05 | Indyk Martin Director | Option exercise | +20,000 | 35,000 | ||
| 2024-06-05 | Indyk Martin Director | Option exercise · Restricted Share Units | −20,000 | 0 | ||
| 2024-06-05 | Harris Keith R. Director | Option exercise | +30,000 | 50,000 | ||
| 2024-06-05 | Harris Keith R. Director | Option exercise · Restricted Share Units | −30,000 | 0 | ||
| 2024-05-28 | Giroux Richard CFO & COO | Gift | −3,000 | 837,426 | ||
| 2024-04-05 | Forbes Alexandria PRESIDENT & CEO | Gift | −1,000 | 1,372,504 | ||
| 2024-03-12 | Forbes Alexandria PRESIDENT & CEO | Gift | −2,000 | 1,373,504 | ||
| 2024-02-29 | Giroux Richard CFO & COO | Gift | −13,500 | 840,426 | ||
| 2024-01-17 | Giroux Richard CFO & COO | Grant or award · Restricted Share Units | +620,000 | 620,000 | ||
| 2024-01-17 | Zeldin Robert K CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-01-17 | Zeldin Robert K CHIEF MEDICAL OFFICER | Grant or award · Restricted Share Units | +70,000 | 70,000 | ||
| 2024-01-17 | Forbes Alexandria PRESIDENT & CEO | Grant or award · Restricted Share Units | +620,000 | 620,000 | ||
| 2024-01-17 | Naylor Stuart CHIEF DEV. OFFICER | Grant or award · Restricted Share Units | +150,000 | 150,000 | ||
| 2024-01-17 | Wollin Robert J GENERAL COUNSEL AND SECRETARY | Grant or award · Restricted Share Units | +100,000 | 100,000 | ||
| 2024-01-14 | Giroux Richard CFO & COO | Option exercise | +25,000 | 867,145 | ||
| 2024-01-14 | Giroux Richard CFO & COO | Shares withheld for taxes | −13,219 | $6.36 | $84K | 853,926 |
| 2024-01-14 | Giroux Richard CFO & COO | Option exercise · Restricted Share Units | −25,000 | 25,000 | ||
| 2024-01-14 | Zeldin Robert K CHIEF MEDICAL OFFICER | Option exercise | +37,500 | 104,480 | ||
| 2024-01-14 | Zeldin Robert K CHIEF MEDICAL OFFICER | Shares withheld for taxes | −14,756 | $6.36 | $94K | 89,724 |
Page 9 of 21 · 411 trades